TASHA MACK: Open Payments
NPI 1184051336 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,285 in 208 payments from 21 companies in 2025. Trend: 2023 $2,850 · 2024 $3,537 · 2025 $3,285
Food & beverage: $3,176Education: $110
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $372 |
| Janssen Biotech, Inc. | 19 | $345 |
| Galderma Laboratories, L.P. | 16 | $318 |
| Regeneron Healthcare Solutions, Inc. | 17 | $298 |
| UCB, Inc. | 20 | $282 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 16 | $229 |
| LEO Pharma Inc. | 14 | $215 |
| Incyte Corporation | 14 | $187 |
| PFIZER INC. | 11 | $176 |
| GENZYME CORPORATION | 5 | $160 |
Products named: DUPIXENT, TREMFYA, NEMLUVIO, Bimzelx, SKYRIZI, OPZELURA, CIBINQO, ADBRY.
Industry payments across AZ — which companies pay providers there.
